In looking at Happiness Biotech Group, I see some potential.
From TOS analysis
- Price/Book .5231
- P/E 6.67
- Free Cash Flow per Share $.52
If Happiness Biotech could return $.52 for the next 3 years, it would essentially generate almost enough free cash flow to cover the cost of stock at $1.74 per share. I really don't think that this stock could get much cheaper in a rational market. Additionally, it looks like the support level is about $1.69 per share which may be a good entry point if it hits that level.
Additionally, they had some good news with a launch of their cross-border ecommerce platform and record sales in March of $14M.
Not investment advice, just my perspective.
From TOS analysis
- Price/Book .5231
- P/E 6.67
- Free Cash Flow per Share $.52
If Happiness Biotech could return $.52 for the next 3 years, it would essentially generate almost enough free cash flow to cover the cost of stock at $1.74 per share. I really don't think that this stock could get much cheaper in a rational market. Additionally, it looks like the support level is about $1.69 per share which may be a good entry point if it hits that level.
Additionally, they had some good news with a launch of their cross-border ecommerce platform and record sales in March of $14M.
Not investment advice, just my perspective.
Komen:
This one has been a panful lesson. I still hold a position in this company, but it never seemed to materialize